CDK4/6 inhibitors induce breast cancer senescence with enhanced anti-tumor immunogenic properties compared with DNA-damaging agents.

Mol Oncol · 2024 · PMC10766199 · PMID 37854019

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

If all the features of CDK4/6i‐induced senescence are less potent than those of DNA‐damaging agents, the implications of this study may not be significant.

also in 1,197 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.